Cardiome Pharma Corp.(NASDAQ:CRME) stock News

CRME Latest News, Press Relases and Analysis

All

Press Releases

7 years ago - By: Smarter Analyst

Cardiome Pharma Corp Gets a Buy Rating from H.C. Wainwright

7 years ago - By: Correvio Pharma Corp

Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV

7 years ago - By: Correvio Pharma Corp

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China

7 years ago - By: Correvio Pharma Corp

Correvio Reports First Quarter 2018 Financial Results

7 years ago - By: Cardiome Pharma Corp.

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

8 years ago - By: Active-Investors - Mentions: APRI

Blog Exposure - Cipher to Acquire Cardiome’s Canadian Business Portfolio for $25.5 Million in Cash

8 years ago - By: Investor Network

Cardiome Pharma Corp. to Host Earnings Call

7 years ago - By: Benzinga - Mentions: CVU FVE ACXM CLMT ...

Earnings Scheduled For May 15, 2018

7 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

7 years ago - By: Cardiome Pharma Corp.

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

7 years ago - By: Cardiome Pharma Corp.

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

8 years ago - By: Cardiome Pharma Corp.

Cardiome Highlights Partner SteadyMed's Progress Towards Trevyent NDA Resubmission

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Recent Insider Purchases

8 years ago - By: Traders News Source

Cardiome Pharma Agrees to Sell Drug Portfolio, Analysts Target Price, Financial Review

8 years ago - By: Cardiome Pharma Corp.

Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review

8 years ago - By: Benzinga

Canaccord: Cardiome Pharma's Sale Of Canadian Business 'A Highly Positive Catalyst' For Shares

8 years ago - By: StockNews.com

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): M&A News

8 years ago - By: Cardiome Pharma Corp.

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

8 years ago - By: Cardiome Pharma Corp.

Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results

8 years ago - By: Cardiome Pharma Corp.

Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13

8 years ago - By: Cardiome Pharma Corp.

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

8 years ago - By: StockNews.com

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Product News News

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen

8 years ago - By: Cardiome Pharma Corp.

Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit

8 years ago - By: StockNews.com

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Corp. News News

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

8 years ago - By: Cardiome Pharma Corp.

Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference

8 years ago - By: Analyst Ratings - Mentions: ALIM LGND

Analysts Are Bullish on These Healthcare Stocks: CRME, ALIM

8 years ago - By: Cardiome Pharma Corp.

Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference

8 years ago - By: StockNews.com

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Earnings News

8 years ago - By: Cardiome Pharma Corp.

Cardiome Reports Third Quarter 2017 Financial Results

8 years ago - By: Cardiome Pharma Corp.

Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14

8 years ago - By: Cardiome Pharma Corp.

Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

8 years ago - By: Cardiome Pharma Corp.

Cardiome Pharma Corp. (CRME) Stock News

CRME Latest News, Press Relases and Analysis

Cardiome Pharma Corp Gets a Buy Rating from H.C. Wainwright

Correvio Pharma Corp, Formerly Cardiome Pharma Corp, Announces Stock Ticker Symbol Change to CORV

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China

Correvio Reports First Quarter 2018 Financial Results

Correvio Pharma Corp Completes Strategic Transaction with Cipher Pharmaceuticals

Blog Exposure - Cipher to Acquire Cardiome’s Canadian Business Portfolio for $25.5 Million in Cash

Cardiome Pharma Corp. to Host Earnings Call

Earnings Scheduled For May 15, 2018

Cardiome Announces Results From Annual and Special Meeting of Shareholders and Timing For First Quarter 2018 Financial Results Conference Call

Cardiome to Present at the Bloom Burton & Co. Healthcare Investor Conference

Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess®

Cardiome Announces Fifteen Xydalba™ and Zevtera® Abstracts at ECCMID 2018

Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

Cardiome Highlights Partner SteadyMed's Progress Towards Trevyent NDA Resubmission

Cardiome Announces Recent Insider Purchases

Cardiome Pharma Agrees to Sell Drug Portfolio, Analysts Target Price, Financial Review

Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review

Canaccord: Cardiome Pharma's Sale Of Canadian Business 'A Highly Positive Catalyst' For Shares

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): M&A News

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cardiome Reports Fourth Quarter and Full Year 2017 Financial Results

Cardiome to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on March 13

Cardiome to Present at the Leerink Partners 7th Annual Global Healthcare Conference

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Product News News

Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen

Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Corp. News News

Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference

Analysts Are Bullish on These Healthcare Stocks: CRME, ALIM

Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference

Cardiome Pharma Corporation - Ordinary Shares (Canada) (CRME): Earnings News

Cardiome Reports Third Quarter 2017 Financial Results

Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14

Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

Cardiome Announces Commercial Launch of Xydalba™ in Three New European Geographies